Therapeutics Bridge Labs (TxBL), launched by MSK in 2025 and embedded within OEC, represents a unique strategic asset among New York City academic research institutions.

Our Care Advisors are here to match you with the right providers for your needs. Finding the right cancer care team can be stressful. We’ll learn about your needs and goals before we put together your ...

Not all thyroid nodules are the same, and neither are their treatments. Most are not cancer. MSK thyroid experts can give you an accurate diagnosis and choose the best treatment. The thyroid is a ...

This resource explains steroid-induced hyperglycemia and the signs and symptoms to watch for. It also explains when to check for hyperglycemia, and tips to help manage blood glucose (blood sugar).

For people living with advanced triple-negative breast cancer (TNBC), a newly approved treatment may offer more time and a better quality of life. TNBC makes up about 10% to 20% of all breast cancers, ...

Memorial Sloan Kettering Cancer Center today announced that Shakeeb Akhter has joined MSK as its new Chief Digital Officer.

MSK gastrointestinal medical oncologist Dr. Wungki Park led the early phase clinical trial of daraxonrasib for people with metastatic pancreatic cancer that had stopped responding to chemotherapy.

How did seed oils get a bad reputation? In recent decades, experts have linked having many highly processed foods to a rise in obesity and health problems, including some cancers. Highly processed ...

A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment, MSK ...

Research at MSK Our research impact Research topics Core facilities & resources ...

Memorial Sloan Kettering Cancer Center (MSK) is ranked the number one hospital in the world for oncology according to Newsweek’s World’s Best Specialized Hospitals 2026 list.

Pattie also was treated by MSK endocrinologist Lubaina Presswala, DO, for an adrenal insufficiency that was caused by her earlier immunotherapy treatments. Dr. Presswala specializes in managing many ...